Loading insider details...
Beta
Latest Form 4 (Jul 10, 2026): Grant/Award of 6,500 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 6,500 | n/a |
| Jun 11, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Grant/Award | 21,000 | n/a |
| Jun 4, 2026 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 7,490 | n/a |
| Jan 6, 2026 | Mersana Therapeutics, Inc. (MRSN) | Tender of Shares | 1,567 | n/a |
| Jun 13, 2025 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 61,500 | n/a |
| Jun 12, 2025 | Metagenomi, Inc. (MGX) | Grant/Award | 21,000 | n/a |
| May 22, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 6,650 | n/a |
| Apr 11, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 100,000 | n/a |
| Jun 12, 2024 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 55,000 | n/a |
| May 23, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 4,720 | n/a |